University of Dundee, MSc Human Clinical Embryology and Assisted Conception - Apply now for September 2018
Page URL: https://www.bionews.org.uk/page_140769

India's lower house passes bill banning commercial surrogacy

14 January 2019
Appeared in BioNews 982

The Lok Sabha, India's lower house, has passed a bill that bans commercial surrogacy.

The Surrogacy (Regulation) Bill 2016 aims to prevent the exploitation of women, in a country that previously had a thriving commercial surrogacy industry. India was a popular fertility tourism destination, leading to concerns that wealthy couples were taking advantage of women of low socioeconomic status, who would act as surrogates.

'There was massive exploitation which forced the regulation, but there is scope to improve the legislation further,' Nirmala Samant Prabhawalkar, a former member of the National Commission for Women, told the Times of India

Surrogacy is only available to couples who have been legally married for a minimum of five years and are aged 26-55 for males and 23-50 for females. Single people, same-sex couples and unmarried cohabiting couples are excluded, as are couples who are already parents (biologically or through adoption) unless their child is mentally or physically disabled or suffers from a life-threatening disorder with no permanent cure. Surrogacy is restricted to resident Indian citizens.

The bill stipulates that the surrogate must be a close relative of one of the intended parents, she must be between 25-35 years old, married (or previously married) and have at least one child of her own. If donor eggs are used, the surrogate cannot also be the egg donor. 

The bill permits altruistic surrogacy only: the surrogate may not receive any payment under the new legislation, and expenses are strictly limited to medical costs. The intended parents are obliged to buy medical insurance for the surrogate, covering the pregnancy and any postpartum complications.

Further provisions in the bill establish a regulatory framework: all surrogacy clinics must be registered, and national and state surrogacy boards will be established to regulate them.  Although surrogates cannot be paid, the new law does not prevent clinics or medical professionals from profiting from surrogacy. 

The bill has received some criticism. 'I think it is a little extreme to ban it completely, we would have liked to have seen better regulation. That way at least it would have remained in the open,' Dr Ranjana Kumari of the Centre for Social Research, a women's rights group based in Delhi told The Telegraph. 'Given the social relations in some Indian societies, there is also a worry that due to power dynamics some females could be coerced into such situations.'

SOURCES & REFERENCES
India bans commercial surrogacy to stop 'rent a womb' exploitation of vulnerable women
The Telegraph |  20 December 2018
Lok Sabha clears Bill banning commercial surrogacy
Times of India |  20 December 2018
Lok Sabha Passes Surrogacy (Regulation) Bill Amid Disruptions
NDTV |  14 January 2019
Surrogacy Bill, then & now
The Indian Express |  21 December 2018
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
17 December 2018 - by Georgia Everett 
A new study into the experience of British families who undertaking surrogacy arrangements has shed light on the reasons some seek a surrogate in the UK while others choose to go abroad...
10 December 2018 - by Eleanor Lynam 
Thirty-two Cambodian women charged with human trafficking for acting as surrogates have been released on bail on the condition that they keep the children...
30 August 2016 - by Julianna Photopoulos 
The Indian government is considering a bill to ban commercial surrogacy, which will only allow Indian couples married for at least five years to use surrogacy.
13 June 2016 - by Stephen Page 
A parliamentary inquiry into surrogacy laws in Australia has just reported its recommendations, but they don't go far enough and the country is likely to remain the world's largest exporters of intended parents...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.